{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:06Z","timestamp":1790803686028,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"M.V.M.","award":["T15LM007033"],"award-info":[{"award-number":["T15LM007033"]}]},{"name":"J.M.O.","award":["R01HL169166"],"award-info":[{"award-number":["R01HL169166"]}]},{"name":"J.M.O.","award":["R01HL166290"],"award-info":[{"award-number":["R01HL166290"]}]},{"name":"J.V.P.","award":["T32HL007749"],"award-info":[{"award-number":["T32HL007749"]}]},{"name":"C.A.N.","award":["K23HL148498"],"award-info":[{"award-number":["K23HL148498"]}]},{"name":"C.A.N.","award":["R01HL176839"],"award-info":[{"award-number":["R01HL176839"]}]},{"name":"J.S.K.","award":["K23HL150301"],"award-info":[{"award-number":["K23HL150301"]}]},{"name":"A.A.","award":["K23HL146942"],"award-info":[{"award-number":["K23HL146942"]}]},{"name":"C.K.G.","award":["R01HL093096"],"award-info":[{"award-number":["R01HL093096"]}]},{"name":"B.B.M.","award":["R35HL176572"],"award-info":[{"award-number":["R35HL176572"]}]},{"name":"P.J.W.","award":["R01HL139897"],"award-info":[{"award-number":["R01HL139897"]}]},{"name":"F.J.M., I.N.","award":["UG3HL145266"],"award-info":[{"award-number":["UG3HL145266"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Interstitial lung diseases (ILDs) are a clinically and biologically diverse group of disorders characterized by varying inflammation and fibrosis of the lung parenchyma. Immunosuppressant therapy is commonly used to treat non-idiopathic pulmonary fibrosis (non-IPF) ILD, but treatment response is variable and difficult to predict.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Identify and validate molecular endotypes of non-IPF ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty plasma proteins associated with inflammation were used to perform latent class analysis in 2 observational non-IPF ILD cohorts (discovery n\u2009=\u2009676; validation n\u2009=\u2009585). Proteins were measured using a semi-quantitative Olink Explore 3072 platform. The primary outcome was 3-year transplant-free survival. Weighted Cox regression was used to assess differential response to mycophenolate or azathioprine in each cohort according to molecular endotype classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A 2-class model best fit both cohorts (P\u2009&amp;lt;0.01), with Class 2 comprising \u223c30% of patients. Compared to Class 1, Class 2 was associated with significantly lower 3-year transplant-free survival in both discovery (78% vs 36%, P\u2009&amp;lt;0.001) and validation (83% vs 46%, P\u2009&amp;lt;0.001) cohorts. Significant interaction between molecular endotype and immunosuppressant exposure was observed in both cohorts (discovery Pinteraction\u2009=\u20090.022; validation Pinteraction\u2009=\u20090.019), with survival benefit seen only in Class 2. In pooled analysis, similar trends were observed irrespective of ILD subtype. Pathway analysis supported enrichment of inflammatory signatures in Class 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this multicenter observational cohort study, we identified and validated 2 distinct molecular endotypes of non-IPF ILD with divergent outcomes and response to immunosuppressant therapy. These endotypes could inform precision medicine strategies and clinical trial design in ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajrccm\/aamag006","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:53:02Z","timestamp":1769086382000},"page":"768-777","source":"Crossref","is-referenced-by-count":3,"title":["Molecular endotypes predict differential response to immunosuppressant therapy in non\u2013idiopathic pulmonary fibrosis interstitial lung disease"],"prefix":"10.1093","volume":"212","author":[{"given":"Manoj V","family":"Maddali","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University , Stanford, CA,","place":["United States"]},{"name":"Department of Biomedical Data Science, Stanford University , Stanford, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle V","family":"Pugashetti","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Michigan , Ann Arbor, MI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8409-4803","authenticated-orcid":false,"given":"Shaun M","family":"Pienkos","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University , Stanford, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Moore","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University , Stanford, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B","family":"Konkol","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Virginia , Charlottesville, VA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Virginia , Charlottesville, VA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwu-Fan","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Virginia , Charlottesville, VA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A","family":"Newton","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center , Dallas, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine K","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Columbia University , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodeji","family":"Adegunsoye","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Chicago , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Strek","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Chicago , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hsien","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California-Davis , Davis, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L","family":"Linderholm","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California-Davis , Davis, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"Zemans","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Michigan , Ann Arbor, MI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany B","family":"Moore","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Michigan , Ann Arbor, MI,","place":["United States"]},{"name":"Department of Microbiology and Immunology, University of Michigan , Ann Arbor, MI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Wolters","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California San Francisco , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Raj","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University , Stanford, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Science, Stanford University , Stanford, CA,","place":["United States"]},{"name":"Center for Biomedical Informatics Research, Stanford University , Stanford, CA,","place":["United States"]},{"name":"Clinical Excellence Research Center, Stanford University , Stanford, CA,","place":["United States"]},{"name":"Division of Hospital Medicine, Stanford University , Stanford, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J","family":"Martinez","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Massachusetts , Worcester, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Noth","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Virginia , Charlottesville, VA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J","family":"Rogers","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University , Stanford, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M","family":"Oldham","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California-Davis , Davis, CA,","place":["United States"]},{"name":"Department of Epidemiology, University of Michigan , Ann Arbor, MI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026052006163901700_aamag006-B1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026052006163901700_aamag006-B2","doi-asserted-by":"publisher","first-page":"2101396","DOI":"10.1183\/13993003.01396-2021","article-title":"Lung function trajectory in progressive fibrosing interstitial lung disease","volume":"59","author":"Oldham","year":"2022","journal-title":"Eur Respir J"},{"key":"2026052006163901700_aamag006-B3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1164\/rccm.202201-0124OC","article-title":"Validation of proposed criteria for progressive pulmonary fibrosis","volume":"207","author":"Pugashetti","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052006163901700_aamag006-B4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/jama.2024.3669","article-title":"Interstitial lung disease: a review","volume":"331","author":"Maher","year":"2024","journal-title":"JAMA"},{"key":"2026052006163901700_aamag006-B5","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"2026052006163901700_aamag006-B6","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"2026052006163901700_aamag006-B7","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"2026052006163901700_aamag006-B8","doi-asserted-by":"publisher","first-page":"17534666221117002","DOI":"10.1177\/17534666221117002","article-title":"Immunomodulatory treatment of interstitial lung disease","volume":"16","author":"van den Bosch","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"2026052006163901700_aamag006-B9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1586\/17476348.2014.880054","article-title":"Immunosuppressive agents and interstitial lung disease: what are the risks?","volume":"8","author":"Meyer","year":"2014","journal-title":"Expert Rev Respir Med"},{"key":"2026052006163901700_aamag006-B10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41584-023-01013-4","article-title":"Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?","volume":"19","author":"Andreasson","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026052006163901700_aamag006-B11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2014","journal-title":"N Engl J Med"},{"key":"2026052006163901700_aamag006-B12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1164\/rccm.202402-0339OC","article-title":"Molecular endotypes of idiopathic pulmonary fibrosis: a latent class analysis of two multicenter observational cohorts","volume":"210","author":"Maddali","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052006163901700_aamag006-B13","doi-asserted-by":"publisher","first-page":"751181","DOI":"10.3389\/fmed.2021.751181","article-title":"Variability in global prevalence of interstitial lung disease","volume":"8","author":"Kaul","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026052006163901700_aamag006-B14","doi-asserted-by":"publisher","first-page":"A2854","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A2854","article-title":"Molecular endotypes predict differential response to immunosuppression in non-IPF interstitial lung disease [abstract]","volume":"211","author":"Maddali","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052006163901700_aamag006-B15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1164\/rccm.202407-1506OC","article-title":"Proteomic biomarkers of survival in non-IPF interstitial lung disease","volume":"211","author":"Alqalyoobi","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052006163901700_aamag006-B16","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"2026052006163901700_aamag006-B17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2015.09.037","article-title":"Amphiregulin may be a new biomarker of classically activated macrophages","volume":"466","author":"Meng","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"2026052006163901700_aamag006-B18","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.3390\/ijms25137313","article-title":"Macrophages as a source and target of GDF-15","volume":"25","author":"Silva-Bermudez","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026052006163901700_aamag006-B19","doi-asserted-by":"publisher","first-page":"765034","DOI":"10.3389\/fimmu.2021.765034","article-title":"The mannose receptor: from endocytic receptor and biomarker to regulator of (meta)inflammation","volume":"12","author":"van der Zande","year":"2021","journal-title":"Front Immunol"},{"key":"2026052006163901700_aamag006-B20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol Rev"},{"key":"2026052006163901700_aamag006-B21","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.4049\/jimmunol.181.10.7243","article-title":"Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis","volume":"181","author":"Mozaffarian","year":"2008","journal-title":"J Immunol"},{"key":"2026052006163901700_aamag006-B22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol"},{"key":"2026052006163901700_aamag006-B23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as immune cell checkpoints in disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"2026052006163901700_aamag006-B24","doi-asserted-by":"publisher","first-page":"788714","DOI":"10.3389\/fphar.2021.788714","article-title":"Latent transforming growth factor-beta binding protein-2 regulates lung fibroblast-to-myofibroblast differentiation in pulmonary fibrosis via NF-kappaB signaling","volume":"12","author":"Zou","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026052006163901700_aamag006-B25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1165\/rcmb.2016-0248PS","article-title":"In the shadow of fibrosis: innate immune suppression mediated by transforming growth factor-beta","volume":"55","author":"Thomas","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026052006163901700_aamag006-B26","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.1002\/jcp.26388","article-title":"Syndecans in chronic inflammatory and autoimmune diseases: pathological insights and therapeutic opportunities","volume":"233","author":"Agere","year":"2018","journal-title":"J Cell Physiol"},{"key":"2026052006163901700_aamag006-B27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/s0945-053x(00)00104-9","article-title":"Thrombospondin 2, a matricellular protein with diverse functions","volume":"19","author":"Bornstein","year":"2000","journal-title":"Matrix Biol"},{"key":"2026052006163901700_aamag006-B28","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"2026052006163901700_aamag006-B29","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.cell.2024.05.015","article-title":"Immune mechanisms in fibrotic interstitial lung disease","volume":"187","author":"Kamiya","year":"2024","journal-title":"Cell"},{"key":"2026052006163901700_aamag006-B30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ki.2010.84","article-title":"Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production","volume":"78","author":"von Vietinghoff","year":"2010","journal-title":"Kidney Int"},{"key":"2026052006163901700_aamag006-B31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s000180050077","article-title":"A cyclic GMP- and G-kinase-dependent effect of azathioprine on migration by human neutrophils","volume":"53","author":"Elferink","year":"1997","journal-title":"Cell Mol Life Sci"},{"key":"2026052006163901700_aamag006-B32","doi-asserted-by":"publisher","first-page":"684699","DOI":"10.3389\/fimmu.2021.684699","article-title":"Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations","volume":"12","author":"Shao","year":"2021","journal-title":"Front Immunol"},{"key":"2026052006163901700_aamag006-B33","doi-asserted-by":"publisher","first-page":"2102146","DOI":"10.1183\/13993003.02146-2021","article-title":"The role of precision medicine in interstitial lung disease","volume":"60","author":"Maher","year":"2022","journal-title":"Eur Respir J"},{"key":"2026052006163901700_aamag006-B34","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1513\/AnnalsATS.201801-067OC","article-title":"Heterogeneity in unclassifiable interstitial lung disease. a systematic review and meta-analysis","volume":"15","author":"Guler","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026052006163901700_aamag006-B35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pharmthera.2016.09.010","article-title":"Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?","volume":"169","author":"Clarke","year":"2017","journal-title":"Pharmacol Ther"},{"key":"2026052006163901700_aamag006-B36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol Rev"},{"key":"2026052006163901700_aamag006-B37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir Res"},{"key":"2026052006163901700_aamag006-B38","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-017-01327-4","article-title":"VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"2026052006163901700_aamag006-B39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.chest.2020.03.037","article-title":"Diagnostic and prognostic biomarkers for chronic fibrosing interstitial lung diseases with a progressive phenotype","volume":"158","author":"Inoue","year":"2020","journal-title":"Chest"},{"key":"2026052006163901700_aamag006-B40","doi-asserted-by":"publisher","first-page":"147993","DOI":"10.1016\/j.gene.2023.147993","article-title":"Mapping the genetic architecture of idiopathic pulmonary fibrosis: meta-analysis and epidemiological evidence of case-control studies","volume":"895","author":"Singh","year":"2024","journal-title":"Gene"},{"key":"2026052006163901700_aamag006-B41","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"2026052006163901700_aamag006-B42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S2213-2600(17)30216-3","article-title":"The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study","volume":"5","author":"Ley","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026052006163901700_aamag006-B43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s13023-024-03410-8","article-title":"Associations between genetic variants of Toll-interacting proteins and interstitial lung diseases: a systematic review and meta-analysis","volume":"19","author":"Li","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"2026052006163901700_aamag006-B44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1164\/rccm.202309-1692OC","article-title":"Machine learning of plasma proteomics classifies diagnosis of interstitial lung disease","volume":"210","author":"Huang","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052006163901700_aamag006-B45","doi-asserted-by":"publisher","first-page":"2002042","DOI":"10.1183\/13993003.02042-2020","article-title":"Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease","volume":"57","author":"Moor","year":"2021","journal-title":"Eur Respir J"},{"key":"2026052006163901700_aamag006-B46","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/rccm.202301-0117OC","article-title":"Proteomic biomarkers of survival in idiopathic pulmonary fibrosis","volume":"209","author":"Oldham","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052006163901700_aamag006-B47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052006163901700_aamag006-B48","doi-asserted-by":"publisher","first-page":"2300441","DOI":"10.1183\/13993003.00441-2023","article-title":"Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease","volume":"62","author":"Zhang","year":"2023","journal-title":"Eur Respir J"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/advance-article-pdf\/doi\/10.1093\/ajrccm\/aamag006\/66675969\/aamag006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/212\/4\/768\/66675969\/aamag006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/212\/4\/768\/66675969\/aamag006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:16:43Z","timestamp":1779272203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/212\/4\/768\/8450234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,1,30]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajrccm\/aamag006","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,30]]}}}